Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value

$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen inventories — Finished Goods ($M) ($M)

Form 10-Q / 10-K Inventories Note (XBRL)

Quarterly Annual

Latest, Q2 2026

1,668

Period ended Jun 30, 2026

Change on a year earlier

-18.2%

2,040 in Q2 2025

History

46 quarters

Since Q1 2015

Sources

Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Inventories — Finished Goods ($M) ($M)	Year on year	Source
Q2 2026	Jun 30, 2026	1,668	-18.2%	Form 10-Q (filed 2026-08-05) ↗
Q1 2026	Mar 31, 2026	1,712	-11.2%	Form 10-Q (filed 2026-05-01) ↗
Q4 2025	Dec 31, 2025	1,885	-8.5%	Form 10-Q (filed 2026-08-05) ↗
Q3 2025	Sep 30, 2025	1,836	-17.9%	Form 10-Q (filed 2025-11-05) ↗
Q2 2025	Jun 30, 2025	2,040	-22.6%	Form 10-Q (filed 2025-08-06) ↗
Q1 2025	Mar 31, 2025	1,927	-23.7%	Form 10-Q (filed 2025-05-02) ↗
Q4 2024	Dec 31, 2024	2,060	-25.8%	Form 10-K (filed 2026-02-13) ↗
Q3 2024	Sep 30, 2024	2,235	+88.6%	Form 10-Q (filed 2024-10-31) ↗
Q2 2024	Jun 30, 2024	2,635	+145.1%	Form 10-Q (filed 2024-08-07) ↗
Q1 2024	Mar 31, 2024	2,526	+123.5%	Form 10-Q (filed 2024-05-03) ↗
Q4 2023	Dec 31, 2023	2,778	+176.7%	Form 10-K (filed 2025-02-14) ↗
Q3 2023	Sep 30, 2023	1,185	+15.4%	Form 10-Q (filed 2023-10-31) ↗
Q2 2023	Jun 30, 2023	1,075	+6.2%	Form 10-Q (filed 2023-08-04) ↗
Q1 2023	Mar 31, 2023	1,130	+4.7%	Form 10-Q (filed 2023-04-28) ↗
Q4 2022	Dec 31, 2022	1,004	-6.3%	Form 10-K (filed 2024-02-14) ↗
Q3 2022	Sep 30, 2022	1,027	-12.4%	Form 10-Q (filed 2022-11-04) ↗
Q2 2022	Jun 30, 2022	1,012	-1.8%	Form 10-Q (filed 2022-08-05) ↗
Q1 2022	Mar 31, 2022	1,079	+13.7%	Form 10-Q (filed 2022-04-28) ↗
Q4 2021	Dec 31, 2021	1,072	+10.5%	Form 10-K (filed 2023-02-09) ↗
Q3 2021	Sep 30, 2021	1,172	+30.9%	Form 10-Q (filed 2021-11-03) ↗
Q2 2021	Jun 30, 2021	1,031	+3.0%	Form 10-Q (filed 2021-08-04) ↗
Q1 2021	Mar 31, 2021	949	-9.1%	Form 10-Q (filed 2021-04-28) ↗
Q4 2020	Dec 31, 2020	970	-2.9%	Form 10-K (filed 2022-02-16) ↗
Q3 2020	Sep 30, 2020	895	-10.1%	Form 10-Q (filed 2020-10-29) ↗
Q2 2020	Jun 30, 2020	1,001	-8.5%	Form 10-Q (filed 2020-07-29) ↗
Q1 2020	Mar 31, 2020	1,044	+7.6%	Form 10-Q (filed 2020-05-01) ↗
Q4 2019	Dec 31, 2019	999	-2.3%	Form 10-Q (filed 2020-05-01) ↗
Q3 2019	Sep 30, 2019	996	+4.0%	Form 10-Q (filed 2019-10-30) ↗
Q2 2019	Jun 30, 2019	1,094	+3.4%	Form 10-Q (filed 2019-07-31) ↗
Q1 2019	Mar 31, 2019	970	-7.6%	Form 10-Q (filed 2019-05-01) ↗
Q4 2018	Dec 31, 2018	1,023	+9.5%	Form 10-Q (filed 2019-10-30) ↗
Q3 2018	Sep 30, 2018	958	-5.3%	Form 10-Q (filed 2018-10-31) ↗
Q2 2018	Jun 30, 2018	1,058	-4.3%	Form 10-Q (filed 2018-07-27) ↗
Q1 2018	Mar 31, 2018	1,050	-9.4%	Form 10-Q (filed 2018-04-25) ↗
Q4 2017	Dec 31, 2017	934	+2.4%	Form 10-K (filed 2019-02-13) ↗
Q3 2017	Sep 30, 2017	1,012	-8.4%	10-Q FY2017 (XBRL) ↗
Q2 2017	Jun 30, 2017	1,106	+15.7%	10-Q FY2017 (XBRL) ↗
Q1 2017	Mar 31, 2017	1,159	+48.0%	10-Q FY2017 (XBRL) ↗
Q4 2016	Dec 31, 2016	912	+29.4%	Form 10-K (filed 2018-02-13) ↗
Q3 2016	Sep 30, 2016	1,105	+14.9%	10-Q FY2016 (XBRL) ↗
Q2 2016	Jun 30, 2016	956	-6.8%	10-Q FY2016 (XBRL) ↗
Q1 2016	Mar 31, 2016	783	-34.3%	10-Q FY2016 (XBRL) ↗
Q4 2015	Dec 31, 2015	705	–	Form 10-K (filed 2017-02-14) ↗
Q3 2015	Sep 30, 2015	962	–	10-Q FY2015 (XBRL) ↗
Q2 2015	Jun 30, 2015	1,026	–	10-Q FY2015 (XBRL) ↗
Q1 2015	Mar 31, 2015	1,192	–	10-Q FY2015 (XBRL) ↗

Cite this data

StockData. (2026). Amgen Inventories — Finished Goods ($M) ($M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/inv_fg

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.